Anti-T Cell pAbs for GVHD Prevention: Does the Addition of ATLG Grafalon to Standard Cyclosporin+Methotrexate Reduce cGVHD Incidence and Improve cGRFS?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

Palliative & Supportive Care
Basic Science
COVID-19
Leukemia
Lymphoma
Myeloma
MDS and MPN
Benign Hematology
Lung
Business
Event

Playback speed

10 seconds

Anti-T Cell pAbs for GVHD Prevention: Does the Addition of ATLG Grafalon to Standard Cyclosporin+Methotrexate Reduce cGVHD Incidence and Improve cGRFS?

By XIth Eurasian Hematology-Oncology Congress - EHOC 2020 FEATURING Francesca Bonifazi

8 views

January 18, 2021

Comments 0

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Making the First Chance Count: Manuel

Feat. A. Ip

Benign Hematology

Haploidentical Transplant in Developing Countries: Challenges, Moder…

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

G. Karasu

19 views

Curative Options for Hemoglobinopathies: Is MSD the SoC in Thalassem…

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

S. Corbacioglu

43 views

Anti-T Cell pAbs for GVHD Prevention: Does the Addition of ATLG Graf…

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

F. Bonifazi

8 views

Bone Marrow Failure: Aplastic Anemias, Telomere Diseases, GATA2 Defi…

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

R. Calado

61 views

Infections in Immunocompromised Patients: Immunodeficiencies in Bone…

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

M. Nucci

30 views

Paroxysmal Nocturnal Hemoglobinuria: Epidemiology, Classification, R…

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

H. Hamed

23 views

2 y/o With Ecchymoses, Hepatosplenomegaly and Cervical Lymphadenopat…

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

C. Coskun

17 views

ASFA Guidelines on the Use of Therapeutic Apheresis: What Does the G…

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

N. Dunbar

19 views

Managing Late Complications in Beta Thalassemia: Thrombotic Disease,…

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

V. Huseynov

25 views

Sickle Cell Disease: Pathogenesis, When to Recommend MSD-SCT, Antico…

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

S. Alkindi

109 views

Hemophilia Treatment in Developing Countries: What Are the Principle…

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

B. Antmen

49 views

ITP Updates: Which Immune Suppressants Should We Use? What Is the Ef…

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

D. Provan

103 views